Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuan-hong Gao
Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
Journal of Cancer
Oncology
Related publications
Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy: A Meta-Analysis
Cancer Management and Research
Oncology
The Role of Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Patterns of Local-Regional Failure After Primary Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Prognostic Values of Hematological Biomarkers in Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy
European Archives of Oto-Rhino-Laryngology
Medicine
Otorhinolaryngology
Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy
PLoS ONE
Multidisciplinary
Prognostic Value of Cavernous Sinus Invasion in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy
PLoS ONE
Multidisciplinary
Impact of Adaptive Intensity-Modulated Radiotherapy on the Neutrophil-To-Lymphocyte Ratio in Patients With Nasopharyngeal Carcinoma
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
The Development and External Validation of Simplified T Category Classification for Nasopharyngeal Carcinoma to Improve the Prognostic Value in the Intensity‐modulated Radiotherapy Era
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
